MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Handschin, C.
Right arrow Articles by Meyer, U. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Handschin, C.
Right arrow Articles by Meyer, U. A.

Vol. 60, Issue 4, 681-689, October 2001

Multiple Enhancer Units Mediate Drug Induction of CYP2H1 by Xenobiotic-Sensing Orphan Nuclear Receptor Chicken Xenobiotic Receptor

Christoph Handschin, Michael Podvinec, Renate Looser, Remo Amherd,1 and Urs A. Meyer

Division of Pharmacology/Neurobiology, Biozentrum of the University of Basel, Basel, Switzerland

Binding of nuclear receptors to drug-responsive enhancer units mediates transcriptional activation of cytochromes P-450 (P-450) by drugs and xenobiotics. In previous studies, a 264-base-pair (bp) phenobarbital-responsive enhancer unit (PBRU) located at -1671 to -1408 upstream of the chicken CYP2H1 transcriptional start-site increased gene expression when activated by the chicken xenobiotic-sensing orphan nuclear receptor CXR. In extension of these studies, we now have functionally analyzed a second distal drug-responsive element and delimited a 643- and a 240-bp PBRU located between 5 and 6 kilobases upstream of the transcriptional start site of CYP2H1. Both PBRUs were activated by CXR after treatment with different drugs. A nuclear receptor binding site, a direct repeat-4 (DR-4) hexamer repeat, was identified on the 240-bp PBRU. Site-directed mutagenesis of this DR-4 abolished activity in reporter gene assays in the chicken hepatoma cells leghorn male hepatoma as well as transactivation of the 240-bp PBRU by CXR in CV-1 cells. CXR bound to this PBRU in electromobility shift assays and the complex remained unaffected by unlabeled 240-bp PBRU with a mutated DR-4. In cross-species experiments, both the human xenobiotic-sensing nuclear receptors pregnane X receptor and constitutive androstane receptor bound to this element, suggesting sequence conservation between chicken and mammalian PBRUs and between the DNA binding domains of these receptors. Of two orphan nuclear receptors involved in cholesterol and bile acid homeostasis, only chicken liver X receptor (LXR) but not chicken farnesoid X receptor bound to the 240-bp PBRU. These results suggest that CYP2H1 induction is explained by the combined effect of multiple distal enhancer elements interacting with multiple transcription factors, including CXR and LXR.

1 Current address: MyoContract, Pharmaceutical Research Ltd., Klingelbergstrasse 70, CH-4056 Basel, Switzerland.

Copyright © 2001 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 J. Lipid Res.Home page
C. Gnerre, G. U. Schuster, A. Roth, C. Handschin, L. Johansson, R. Looser, P. Parini, M. Podvinec, K. Robertsson, J.-A. Gustafsson, et al.
LXR deficiency and cholesterol feeding affect the expression and phenobarbital-mediated induction of cytochromes P450 in mouse liver
J. Lipid Res., August 1, 2005; 46(8): 1633 - 1642.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
C. Handschin and U. A. Meyer
Induction of Drug Metabolism: The Role of Nuclear Receptors
Pharmacol. Rev., December 1, 2003; 55(4): 649 - 673.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
S. C. Dogra, D. Tremethick, and B. K. May
Evidence That the Coactivator CBP/p300 Is Important for Phenobarbital-Induced but Not Basal Expression of the CYP2H1 Gene
Mol. Pharmacol., January 1, 2003; 63(1): 73 - 80.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
S. S. Ferguson, E. L. LeCluyse, M. Negishi, and J. A. Goldstein
Regulation of Human CYP2C9 by the Constitutive Androstane Receptor: Discovery of a New Distal Binding Site
Mol. Pharmacol., September 1, 2002; 62(3): 737 - 746.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. Handschin, M. Podvinec, R. Amherd, R. Looser, J.-C. Ourlin, and U. A. Meyer
Cholesterol and Bile Acids Regulate Xenosensor Signaling in Drug-mediated Induction of Cytochromes P450
J. Biol. Chem., August 9, 2002; 277(33): 29561 - 29567.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
M. Podvinec, M. R. Kaufmann, C. Handschin, and U. A. Meyer
NUBIScan, an in Silico Approach for Prediction of Nuclear Receptor Response Elements
Mol. Endocrinol., June 1, 2002; 16(6): 1269 - 1279.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Baader, C. Gnerre, J. J. Stegeman, and U. A. Meyer
Transcriptional Activation of Cytochrome P450 CYP2C45 by Drugs Is Mediated by the Chicken Xenobiotic Receptor (CXR) Interacting with a Phenobarbital Response Enhancer Unit
J. Biol. Chem., May 3, 2002; 277(18): 15647 - 15653.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2001 by the American Society for Pharmacology and Experimental Therapeutics